Located in the North Country of Potsdam NY; Clark Scientific has developed a technology that allows us to rapidly and efficiently produce large volumes of protein specific, biochemical data.
These parameters include:
Our platform is:
Biopharmaceuticals could become the core of the pharmaceutical industry, but not without significant transformation in the laboratory and in strategy, technology, and operations. Biopharmaceuticals are among the most sophisticated and elegant achievements of modern science. Yet there are operational and technological challenges. The “machines” or proteins that are used in recombinant therapeutics are usually modified enzymes that must be frozen for storage, thawed without damage, and made to thrive in the unusual environment of a reaction vessel. The molecules must then be separated from the cells that made them and the media in which they were produced, all without destroying their complex, fragile structures. Although these products are very good at their job all this sophistication comes at great cost. Large-scale biotech- manufacturing facilities require $30 million to $100 million or more and can take several years to build. These facilities are costly to run with long process durations, low yields, expensive raw materials, and, not least, the need for a team of highly skilled experts to operate them.
So, what would it be worth to have all this data at your fingertips?